Us2.ai Revenue and Competitors

Location

N/A

Total Funding

AI

Industry

Estimated Revenue & Valuation

  • Us2.ai's estimated annual revenue is currently $3.7M per year.(i)
  • Us2.ai's estimated revenue per employee is $112,000

Employee Data

  • Us2.ai has 33 Employees.(i)
  • Us2.ai grew their employee count by 0% last year.

Us2.ai's People

NameTitleEmail/Phone
1
Head EngineeringReveal Email/Phone
2
Data ScientistReveal Email/Phone
3
Performance ManagerReveal Email/Phone
4
Technical Program ManagerReveal Email/Phone
5
Regional Business ManagerReveal Email/Phone
6
Business Development ManagerReveal Email/Phone
7
President / Co-founderReveal Email/Phone
8
Clinical Application SpecialistReveal Email/Phone
9
Business Development Manager - Northern EuropeReveal Email/Phone
10
Clinical Application SpecialistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.3M4N/AN/AN/A
#2
$3.4M307%N/AN/A
#3
$27M17526%N/AN/A
#4
$7.7M610%N/AN/A
#5
$175.6M877-6%$91.2MN/A
#6
$1.5M18-5%N/AN/A
#7
$2M20N/AN/AN/A
#8
$0.2M3-70%N/AN/A
#9
$32M20841%N/AN/A
#10
$1.3M16-33%N/AN/A
Add Company

What Is Us2.ai?

keywords:N/A

N/A

Total Funding

33

Number of Employees

$3.7M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Us2.ai News

2022-04-20 - Financing round-up: Rona Therapeutics, Us2.ai, CDR-Life ...

Financing round-up: Rona Therapeutics, Us2.ai, CDR-Life, Phablecare, Prilenia Therapeutics. By. Nick Herbert. -. 22nd April 2022.

2022-04-19 - Us2.ai secures US$15 mil Series A to improve detection of ...

Us2.ai announced that it has raised US$15 million (RM63.8 million) in a Series A round led by IHH Healthcare and Heal Partners,...

2022-04-13 - Singapore Medtech firm Us2.ai raises $15m from IHH ...

Singapore-based medical technology startup Us2.ai has raised $15 million in a Series A round led by IHH Healthcare and Australian health and...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$6M33-43%N/A
#2
$7.5M333%N/A
#3
$4.8M3332%N/A
#4
$4.2M336%N/A
#5
$6.7M330%N/A